FindTrial
Sign In

Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded to non-surgical treatment favorably.

Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded to non-surgical treatment favorably. - Conversion surgery for patients with UR-PC

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000031131
Enrollment
34
Registered
2018-02-07
Start date
2018-02-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable pancreatic cancer

Interventions

None listed

Sponsors

Hokkaido University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: I) Patients diagnosed as unresectable pancreatic cancer II) Patients with favorable responses to non-surgical treatment III) Patients who underwent conversion surgery IV) Patients who refuse to participate in this research

Exclusion criteria

Exclusion criteria: Patients judged inappropriate as research subjects by research managers

Design outcomes

Primary

MeasureTime frame
Overall survival—

Countries

Japan

Contacts

Public ContactToshimichi Asano

Hokkaido University Faculty of Medicine Department of Gastroenterological Surgery II

toasa0616@gmail.com011-706-7714

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026